Piperidolate

DB13351

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 323.436
Wujud -

Peta Jejaring Molekuler
Legenda: Obat • Target • Gen • Enzim • (Panah → menunjukkan arah efek / relasi) • Transporter • Carrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

516 Data
Aclidinium The risk or severity of adverse effects can be increased when Piperidolate is combined with Aclidinium.
Mianserin Mianserin may increase the anticholinergic activities of Piperidolate.
Mirabegron The risk or severity of urinary retention can be increased when Piperidolate is combined with Mirabegron.
Pramlintide The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Piperidolate.
Secretin porcine The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Piperidolate.
Tiotropium The risk or severity of adverse effects can be increased when Piperidolate is combined with Tiotropium.
Topiramate The risk or severity of hyperthermia and oligohydrosis can be increased when Piperidolate is combined with Topiramate.
Umeclidinium The risk or severity of adverse effects can be increased when Piperidolate is combined with Umeclidinium.
Glycopyrronium The risk or severity of adverse effects can be increased when Piperidolate is combined with Glycopyrronium.
Botulinum toxin type A The risk or severity of adverse effects can be increased when Piperidolate is combined with Botulinum toxin type A.
Glucagon Piperidolate may increase the gastrointestinal motility reducing activities of Glucagon.
Sulpiride Piperidolate may increase the anticholinergic activities of Sulpiride.
Botulinum toxin type B The risk or severity of adverse effects can be increased when Piperidolate is combined with Botulinum toxin type B.
Eluxadoline The risk or severity of constipation can be increased when Piperidolate is combined with Eluxadoline.
Ramosetron The risk or severity of constipation can be increased when Piperidolate is combined with Ramosetron.
Naltrexone The risk or severity of adverse effects can be increased when Piperidolate is combined with Naltrexone.
Bezitramide The risk or severity of adverse effects can be increased when Piperidolate is combined with Bezitramide.
Tramadol The risk or severity of adverse effects can be increased when Piperidolate is combined with Tramadol.
Morphine The risk or severity of adverse effects can be increased when Piperidolate is combined with Morphine.
Codeine The risk or severity of adverse effects can be increased when Piperidolate is combined with Codeine.
Hydromorphone The risk or severity of adverse effects can be increased when Piperidolate is combined with Hydromorphone.
Methadone The risk or severity of adverse effects can be increased when Piperidolate is combined with Methadone.
Meperidine The risk or severity of adverse effects can be increased when Piperidolate is combined with Meperidine.
Oxycodone The risk or severity of adverse effects can be increased when Piperidolate is combined with Oxycodone.
Butorphanol The risk or severity of adverse effects can be increased when Piperidolate is combined with Butorphanol.
Dextropropoxyphene The risk or severity of adverse effects can be increased when Piperidolate is combined with Dextropropoxyphene.
Pentazocine The risk or severity of adverse effects can be increased when Piperidolate is combined with Pentazocine.
Sufentanil The risk or severity of adverse effects can be increased when Piperidolate is combined with Sufentanil.
Alfentanil The risk or severity of adverse effects can be increased when Piperidolate is combined with Alfentanil.
Fentanyl The risk or severity of adverse effects can be increased when Piperidolate is combined with Fentanyl.
Nalbuphine The risk or severity of adverse effects can be increased when Piperidolate is combined with Nalbuphine.
Levorphanol The risk or severity of adverse effects can be increased when Piperidolate is combined with Levorphanol.
Remifentanil The risk or severity of adverse effects can be increased when Piperidolate is combined with Remifentanil.
Buprenorphine The risk or severity of adverse effects can be increased when Piperidolate is combined with Buprenorphine.
Hydrocodone The risk or severity of adverse effects can be increased when Piperidolate is combined with Hydrocodone.
Diphenoxylate The risk or severity of adverse effects can be increased when Piperidolate is combined with Diphenoxylate.
Oxymorphone The risk or severity of adverse effects can be increased when Piperidolate is combined with Oxymorphone.
Dezocine The risk or severity of adverse effects can be increased when Piperidolate is combined with Dezocine.
Levacetylmethadol The risk or severity of adverse effects can be increased when Piperidolate is combined with Levacetylmethadol.
Methadyl acetate The risk or severity of adverse effects can be increased when Piperidolate is combined with Methadyl acetate.
Dihydroetorphine The risk or severity of adverse effects can be increased when Piperidolate is combined with Dihydroetorphine.
Diamorphine The risk or severity of adverse effects can be increased when Piperidolate is combined with Diamorphine.
Ethylmorphine The risk or severity of adverse effects can be increased when Piperidolate is combined with Ethylmorphine.
Etorphine The risk or severity of adverse effects can be increased when Piperidolate is combined with Etorphine.
Dextromoramide The risk or severity of adverse effects can be increased when Piperidolate is combined with Dextromoramide.
Desomorphine The risk or severity of adverse effects can be increased when Piperidolate is combined with Desomorphine.
Carfentanil The risk or severity of adverse effects can be increased when Piperidolate is combined with Carfentanil.
Dihydrocodeine The risk or severity of adverse effects can be increased when Piperidolate is combined with Dihydrocodeine.
Alphacetylmethadol The risk or severity of adverse effects can be increased when Piperidolate is combined with Alphacetylmethadol.
Dihydromorphine The risk or severity of adverse effects can be increased when Piperidolate is combined with Dihydromorphine.
Tapentadol The risk or severity of urinary retention and constipation can be increased when Piperidolate is combined with Tapentadol.
Ketobemidone The risk or severity of adverse effects can be increased when Piperidolate is combined with Ketobemidone.
DPDPE The risk or severity of adverse effects can be increased when Piperidolate is combined with DPDPE.
Lofentanil The risk or severity of adverse effects can be increased when Piperidolate is combined with Lofentanil.
Opium The risk or severity of adverse effects can be increased when Piperidolate is combined with Opium.
Normethadone The risk or severity of adverse effects can be increased when Piperidolate is combined with Normethadone.
Piritramide The risk or severity of adverse effects can be increased when Piperidolate is combined with Piritramide.
Alphaprodine The risk or severity of adverse effects can be increased when Piperidolate is combined with Alphaprodine.
Nicomorphine The risk or severity of adverse effects can be increased when Piperidolate is combined with Nicomorphine.
Meptazinol The risk or severity of adverse effects can be increased when Piperidolate is combined with Meptazinol.
Phenoperidine The risk or severity of adverse effects can be increased when Piperidolate is combined with Phenoperidine.
Phenazocine The risk or severity of adverse effects can be increased when Piperidolate is combined with Phenazocine.
Tilidine The risk or severity of adverse effects can be increased when Piperidolate is combined with Tilidine.
Carfentanil, C-11 The risk or severity of adverse effects can be increased when Piperidolate is combined with Carfentanil, C-11.
Benzhydrocodone The risk or severity of adverse effects can be increased when Piperidolate is combined with Benzhydrocodone.
Naloxegol The risk or severity of adverse effects can be increased when Piperidolate is combined with Naloxegol.
Trospium The risk or severity of adverse effects can be increased when Trospium is combined with Piperidolate.
Oxyphenonium The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Piperidolate.
Benzatropine The risk or severity of adverse effects can be increased when Benzatropine is combined with Piperidolate.
Disopyramide The risk or severity of adverse effects can be increased when Disopyramide is combined with Piperidolate.
Metixene The risk or severity of adverse effects can be increased when Metixene is combined with Piperidolate.
Terfenadine The risk or severity of adverse effects can be increased when Terfenadine is combined with Piperidolate.
Buclizine The risk or severity of adverse effects can be increased when Buclizine is combined with Piperidolate.
Trihexyphenidyl The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Piperidolate.
Oxyphencyclimine The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Piperidolate.
Procyclidine The risk or severity of adverse effects can be increased when Procyclidine is combined with Piperidolate.
Hyoscyamine The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Piperidolate.
Methscopolamine bromide The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Piperidolate.
Darifenacin The risk or severity of adverse effects can be increased when Darifenacin is combined with Piperidolate.
Tridihexethyl The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Piperidolate.
Anisotropine methylbromide The risk or severity of adverse effects can be increased when Anisotropine methylbromide is combined with Piperidolate.
Atropine The risk or severity of adverse effects can be increased when Atropine is combined with Piperidolate.
Nicardipine The risk or severity of adverse effects can be increased when Nicardipine is combined with Piperidolate.
Mecamylamine The risk or severity of adverse effects can be increased when Mecamylamine is combined with Piperidolate.
Pirenzepine The risk or severity of adverse effects can be increased when Pirenzepine is combined with Piperidolate.
Homatropine methylbromide The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Piperidolate.
Benzquinamide The risk or severity of adverse effects can be increased when Benzquinamide is combined with Piperidolate.
Propantheline The risk or severity of adverse effects can be increased when Propantheline is combined with Piperidolate.
Dicyclomine The risk or severity of adverse effects can be increased when Dicyclomine is combined with Piperidolate.
Tropicamide The risk or severity of adverse effects can be increased when Tropicamide is combined with Piperidolate.
Cocaine The risk or severity of adverse effects can be increased when Cocaine is combined with Piperidolate.
Quinidine The risk or severity of adverse effects can be increased when Quinidine is combined with Piperidolate.
Amantadine The risk or severity of adverse effects can be increased when Amantadine is combined with Piperidolate.
Methantheline The risk or severity of adverse effects can be increased when Methantheline is combined with Piperidolate.
Cycrimine The risk or severity of adverse effects can be increased when Cycrimine is combined with Piperidolate.
Cyclopentolate The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Piperidolate.
Tolterodine The risk or severity of adverse effects can be increased when Tolterodine is combined with Piperidolate.
Oxybutynin The risk or severity of adverse effects can be increased when Oxybutynin is combined with Piperidolate.
Pentolinium The risk or severity of adverse effects can be increased when Pentolinium is combined with Piperidolate.
Trimethaphan The risk or severity of adverse effects can be increased when Trimethaphan is combined with Piperidolate.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul